thank you very much for your time, dr robert matiru from unitaid.e tehran museum of contemporary art in iran. the masterpieces had been left for decades in the museum's storage, away from the public�*s eye. sara monetta reports. bright colours, nervous lines, andy warhol's work is unmistakable. but these paintings are even more extraordinary because they've never been seen before. now they're on display for the first time in their home, tehran. translation: when i heard about a new exhibition - on andy warhol, i thought it was happening abroad. but no, it's happening here. it's a real surprise. i didn't know we had any warhol work. these, like hundreds of other pieces, were bought in the 1960s, by iran's empress, who posed for warhol herself. after the iranian revolution in 1979, these artworks remained locked away from sight in the museum's storage. the empress�* collection is one of the largest in the world, it counts 3,500 masterpieces and has been valued at over three billion euros. the museum's curators think it's time to start sharing their tr

robert matiru is the director of programmes at global health agency unitaid.s really important about this milestone is that this is the first time that a generic version appropriately formulated of the best treatment has been made available for the youngest infants and toddlers. for now, this age group with children as young as four weeks order four kilograms of had to endure having adult tablets crushed. not getting the right amount of active ingredient for the treatment for hiv. and if that received the most attractive treatment. for of this most effective treatment for hiv and it's really great that after three years of the adult version being available, we managed to have a generic formulation made available for children that is a record time for a better drug for children. and it's cheaper? yes, this is a public—private partnership between the axis initiative and industry partners. the partner they can do to this medicine and manufacturers in india if you agree to receive the patent, the intellectual property to make this medicine. it is 75% cheaper than